Utilization of antihypertensive drugs in certain European countries D. CapellàM. PortaJ. R. Laporte Originals Pages: 431 - 435
Family study of genetic and environmental factors determining the protein binding of propranolol G. AlvánK. BergströmN. Pedersen Originals Pages: 437 - 441
Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution D. B. Jack Originals Pages: 443 - 448
Pharmacokinetics of canrenone after oral administration of spironolactone and intravenous injection of canrenoate-K in healthy man W. KrauseJ. KarrasW. Seifert Originals Pages: 449 - 453
Rapid achievement of a serum concentration plateau of digoxin through controlled infusion M. WeissW. SziegoleitW. Förster Originals Pages: 455 - 457
Relative immunosuppressive potency of various corticosteroids measured in vitro E. LanghoffJ. Ladefoged Originals Pages: 459 - 462
Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure J. R. KiechelD. LaveneJ. P. Fillastre Originals Pages: 463 - 466
Pharmacokinetics of oral hydralazine in chronic heart failure A. HansonB. W. JohanssonL. Å. Wåhlander Originals Pages: 467 - 473
Hypotensive effects of diltiazem to normals and essential hypertensives K. AokiK. SatoM. Yamamoto Originals Pages: 475 - 480
Chronic propranolol administration during pregnancy M. T. SmithI. LivingstoneE. J. Triggs Originals Pages: 481 - 490
IgA in epileptics receiving anticonvulsant therapy O. MeissnerH. F. JoubertW. Studzinski Originals Pages: 491 - 495
Pharmacokinetics of methadone in methadone maintenance treatment: Characterization of therapeutic failures M. -I. NilssonL. GrönbladhE. Änggård Originals Pages: 497 - 501
Systolic time intervals during long-term beta-blockade with alprenol in ischaemic heart disease S. Lind RasmussenF. PedersenP. B. Nielsen Originals Pages: 503 - 506
Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man C. FischerK. MaierU. Klotz Originals Pages: 511 - 515
Effect of coadministration of verapamil and quinidine on serum digoxin concentration W. Doering Originals Pages: 517 - 521
Diazoxide and labetalol in acute hypertension during haemodialysis G. KeuschH. SchifflU. Binswanger Originals Pages: 523 - 527
Pharmacodynamic and pharmacokinetic study of oral and intravenous penbutolol J. A. VedinC. WilhelmssonL. -E. Peterson Originals Pages: 529 - 534
The variance of forearm blood flow as an indicator of emotional stress Ch. BreierH. KainH. Konzett Originals Pages: 535 - 538
Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure D. N. SharpeR. Coxon Originals Pages: 539 - 545
The effects of astemizole on histamine-induced weal and flare D. N. BatemanP. H. ChapmanM. D. Rawlins Originals Pages: 547 - 551
Endralazine — A new hydralazine-like antihypertensive with high systemic bioavailability P. A. ReeceI. CozamanisR. Zacest Originals Pages: 553 - 556
Pinacidil, a new vasodilator: Pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension J. E. CarlsenT. KardelJ. Trap-Jensen Originals Pages: 557 - 561
The H1-antagonist mequitazine: Studies on performance and visual function A. N. NicholsonB. M. Stone Originals Pages: 563 - 566
Lack of effect of astemizole on ethanol dynamics or kinetics D. N. BatemanP. H. ChapmanM. D. Rawlins Short Communication Pages: 567 - 568
Variability of plasma drug concentrations: Some observations D. B. JackM. R. WilkinsP. E. Hall Letter To The Editors Pages: 569 - 570
